Clinical Trials Logo

Developmental Delays clinical trials

View clinical trials related to Developmental Delays.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02523989 Completed - Clinical trials for Developmental Delays

The Relationship Between Arsenic Methylation Capability and Blood Metals in Children With Developmental Delays

Start date: March 2010
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to explore the relationship between arsenic methylation and blood metals in children with developmental delays and its correlation with health related quality of life.

NCT ID: NCT02184715 Completed - Clinical trials for Developmental Delays

Effects of Virtual Reality System in Children With Developmental Delays

Start date: January 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effects of virtual reality system on children with developmental delays.

NCT ID: NCT01441674 Completed - Stroke Clinical Trials

Animal Assisted Therapy in a Pediatric Setting

AAT
Start date: January 2011
Phase: Phase 1/Phase 2
Study type: Interventional

The primary purpose for this study is to determine if children who receive Occupational Therapy while they are an inpatient in the hospital will be more motivated to participate in therapy as well as increase the amount of time they will work during that particular session when a therapy dog is present during their sessions. The investigators will also be collecting data regarding a child's heart rate and blood pressure prior to the session starting and ending to determine if having a therapy dog present also helps relax a child.

NCT ID: NCT00844246 Completed - Clinical trials for Developmental Delays

Translating Evidence Based Developmental Screening Into Pediatric Primary Care

TEDS
Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.